The AMSCG was created in 2005.
The primary role of the AMSCG is to look at practical and operational issues of common interest for all the IFs in the areas of medical and anti-doping activity, including all athletes’ health related matters. The AMSCG can also be called upon to give its opinion about the work of WADA as well as content of the WADA Board Meetings. The group usually meets twice a year.
The AMSCG is chaired by Dr. Margo Mountjoy (CAN). The Canadian sports medicine physician is a member of the FINA Bureau, of the Games Working Group of the IOC’s Medical Commission as well as of WADA’s TUE (Therapeutic Use Exemption) Committee.
Members of the group are: